30 September 2021
Promoting Diversity, Equity, and Inclusion in Parkinson’s Research and Care
Current knowledge about Parkinson’s disease (PD) does not reflect the diversity of people with the disease, according to The Michael J. Fox Foundation for Parkinson’s Research (MJFF). In a position paper published in JPD, MJFF research staff define four major areas of action to reduce health disparities and advance treatments for everyone with PD. It highlights steps the Foundation is taking in these areas, including a new program launched earlier this year.
23 September 2021
Pipeline of Cell and Gene Therapies Holds Promise for Repairing the Parkinsonian Brain
After several decades of pre-clinical development, cell- and gene-based therapies for Parkinson’s disease (PD) are now actively being explored. In this JPD special issue on “Repairing the Parkinsonian Brain,” experts highlight some of the current strategies being pursued to restore lost function and replace what is lost in the PD brain, with special emphasis on the challenges associated with translating advanced therapeutic approaches into pioneering clinical trials.
31 August 2021
New Study Sheds Light on Lives of People with Parkinson’s and their Carers
Results of a new European study published in JPD may help improve clinical practice by shedding light on the lives of people with PD and their carers, re-emphasizing the many challenges they face in everyday life.
30 August 2021
New Study Urges Neurologists to Advocate Vaccinations for Patients with Parkinson’s
Patients with Parkinson’s disease (PD) are at higher risk for vaccine-preventable respiratory illnesses. However, patients with advanced PD may have less access to vaccinations according to a new study published in the JPD. More than 30% of patients surveyed did not know whether their physicians
20 July 2021
Digital Technology Driving Tangible Advancements in Parkinson’s Disease Research and Clinical Care
Amsterdam, NL – Well over six million people globally have been diagnosed with Parkinson’s disease (PD), which has an enormous impact on the lives of patients, their families, and caregivers and is incurring mounting costs for society.
29 April 2021
International Task Force Determines Current Parkinson’s Disease Subtyping May Not Fit All Patients
28 April 2021
New Model May Explain the Mystery of Asymmetry in Parkinson’s Disease
Amsterdam, NL – Parkinson’s disease (PD) is characterized by slowness of movement and tremors, which often appear asymmetrically in patients.
26 April 2021
Which Parkinson’s Symptoms Do Patients Most Want to See Improved by Treatment?
Amsterdam, NL – Individuals with Parkinson’s disease (PD) face a wide range of symptoms and challenges.
3 February 2021
COVID-19 Vaccination for Patients with Parkinson’s Disease Recommended
Patients with Parkinson’s disease (PD) and healthcare professionals caring for them have expressed concerns about the COVID-19 vaccine’s efficacy and safety in the specific context of PD and its symptomatic treatment. In a commentary just published in JPD, a set of experts addresses these concerns from an evidence-based perspective. Their conclusion is that COVID-19 vaccination with approved vaccines should be recommended to persons with PD, unless there is a specific contraindication.
26 January 2021
Over Half of Cannabis Users with Parkinson’s Disease Report Clinical Benefits
Amsterdam, NL – With medicinal cannabis now legalized in many parts of the world, there is growing interest in its use to alleviate symptoms of many illnesses including Parkinson’s disease (PD).
Pages
